Skip to main content
S. 2842 115th Congress Senate

Opioid Addiction Recovery Fraud Prevention Act of 2018

Official title: A bill to prohibit the marketing of bogus opioid treatment programs or products.

Introduced: May 15, 2018 Introduced by: Shelley Moore Capito Republican · West Virginia See on congress.gov
Commerce Civil actions and liabilityConsumer affairsDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substances
More subjectsShow fewer subjects
Drug, alcohol, tobacco useFederal preemptionFraud offenses and financial crimesHealth promotion and preventive careMarketing and advertisingState and local government operations
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 27, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 490.
Jun 27, 2018
Committee on Commerce, Science, and Transportation. Reported by Senator Thune with an amendment in the nature of a substitute. With written report No. 115-285.
May 22, 2018
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 15, 2018
Read twice and referred to the Committee on Commerce, Science, and Transportation.
May 15, 2018
Introduced in Senate
 Amendments to this bill 1

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

AmendmentSponsorPurposeStatusLatest action
SAMDT 2,251 Capito, Shelley Moore – No recorded outcome May 17, 2018
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 27, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 490.

 Plain-English summary Congressional Research Service

Opioid Addiction Recovery Fraud Prevention Act of 2018

This bill prohibits deceptive representation regarding the cost, price, efficacy, performance, benefit, risk, or safety of opioid treatment programs or products.

 Related & companion bills 1
  • HR 6 SUPPORT for Patients and Communities Act
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1 Republican 1
R
Sullivan, Dan
Alaska · May 21, 2018
 D
Cortez Masto, Catherine
Nevada · May 15, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2842: Opioid Addiction Recovery Fraud Prevention Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2842/
MLA
"S. 2842: Opioid Addiction Recovery Fraud Prevention Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2842/.
Bluebook (legal)
S. 2842, 115th Cong. (2026), https://openamerica.io/bill/115-S-2842/.
Markdown link
[S. 2842: Opioid Addiction Recovery Fraud Prevention Act of 2018](https://openamerica.io/bill/115-S-2842/)
Report a problem